BlackRock
OMGA

BlackRock’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

BlackRock’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-272,051
Closed -$203K – 5552
2024
Q4 		$203K Buy
272,051
+400
+0.1% +$399 ﹤0.01% 4617
2024
Q3 		$331K Sell
271,651
-92,302
-25% -$147K ﹤0.01% 4422
2024
Q2 		$753K Sell
363,953
-1,051,475
-74% -$2.48M ﹤0.01% 4250
2024
Q1 		$5.17M Buy
1,415,428
+33,148
+2% +$127K ﹤0.01% 3661
2023
Q4 		$4.16M Sell
1,382,280
-147,659
-10% -$299K ﹤0.01% 3758
2023
Q3 		$3.29M Sell
1,529,939
-79,747
-5% -$319K ﹤0.01% 3830
2023
Q2 		$9.01M Buy
1,609,686
+1,062,612
+194% +$8.31M ﹤0.01% 3466
2023
Q1 		$3.3M Sell
547,074
-26,763
-5% -$186K ﹤0.01% 3819
2022
Q4 		$3.28M Sell
573,837
-83,285
-13% -$467K ﹤0.01% 3916
2022
Q3 		$3.56M Sell
657,122
-39,262
-6% -$199K ﹤0.01% 3907
2022
Q2 		$2.65M Sell
696,384
-1,209,004
-63% -$4.5M ﹤0.01% 4122
2022
Q1 		$11.9M Buy
1,905,388
+873,823
+85% +$8.92M ﹤0.01% 3481
2021
Q4 		$11.7M Buy
1,031,565
+73,389
+8% +$1.4M ﹤0.01% 3585
2021
Q3 		$18.1M Buy
+958,176
New +$18.4M ﹤0.01% 3356

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

BlackRock's OMGA Position: Q1 2025 in Review

BlackRock sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 272,051 shares — an estimated $203K sold.

BlackRock first reported a position in OMGA in Q3 2021 and held it in 14 quarters. The position peaked at $18.1M in Q3 2021. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • BlackRock reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • BlackRock sold 272,051 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $203K.
  • BlackRock first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 14 quarters.
  • BlackRock's Omega Therapeutics, Inc. Common Stock position peaked at $18.1M in Q3 2021.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on BlackRock's 13F filing for Q1 2025, filed 2 May 2025.